S-1/A: International Battery Metals Files S-1/A for Resale of Shares and Warrants, Details Financial Losses and Strategic Path Forward
Registration Statement Amendment
International Battery Metals Ltd. filed an S-1/A registration statement to allow selling shareholders to resell up to 93.48 million common shares and 39.22 million warrants, while disclosing continued operating losses and outlining its strategy for modular direct lithium extraction technology.
Summary
- International Battery Metals Ltd. (IBAT) is an advanced technology and manufacturing company focused on environmentally responsible methods of extracting lithium compounds from brine, currently operating as a pre-revenue company.
- The company's proprietary Modular Direct Lithium Extraction (MDLE) Plant technology is designed to extract lithium chloride from brine, which can then be processed into high-purity lithium carbonate (over 99% purity demonstrated).
- A commercial-scale demonstration project of the first MDLE Plant with US Magnesium produced approximately 25 tons of battery-grade lithium carbonate, but the project was terminated in September 2024 due to low lithium demand and market prices impacting US Magnesium's profitability.
- The MDLE Plant was decommissioned from US Magnesium's site and relocated to an offsite storage facility, and the company is actively marketing it to potential customers.
- The company incurred a net loss of $3.5 million for the fiscal year ended March 31, 2025, compared to $8.5 million for the fiscal year ended March 31, 2024.
- As of March 31, 2025, the company had an accumulated deficit of approximately $39.6 million and working capital of approximately $10.6 million.
- The company raised approximately $24.4 million from private placements in the fiscal year ended March 31, 2025, and an additional $5.0 million is expected from the 2025 Encompass Offering, anticipated to close around August 8, 2025.
- The company is developing a second generation of MDLE Plant technology, anticipating increased capacity for processing brine solutions and lithium chloride production, with estimated costs of $500,000 for instrumentation and engineering and $250,000 for construction and testing of larger columns.
- The company holds four issued patents and twenty-four pending patent applications related to its core technologies, and nine registered trademarks with fifteen pending trademark applications.
- A legal proceeding with former employees and directors, Christina Borgese and Marc Privitera, seeking specific performance and damages, was settled on July 14, 2025, with the company paying approximately $78,000 to the claimants.
Sentiment
Score: 3
Explanation: The company is in a challenging pre-revenue stage with significant accumulated losses and a recently terminated key demonstration project. While it has a promising technology and has successfully raised capital, the lack of current revenue, reliance on future capital raises, and the material weakness in internal controls indicate high operational and financial risk. The positive aspects of its technology are offset by the commercialization hurdles and market volatility.
Positives
- Proprietary MDLE Plant technology demonstrated commercial-scale production of battery-grade lithium carbonate with over 99% purity.
- Achieved high lithium extraction (81% average) and recovery to product (69% average) in a September 2022 pilot test, with a third-party lab confirming 95% overall recovery in June 2023.
- The DLE technology is highly selective for lithium ions, reducing cycles, energy consumption, and eliminating most chemicals, leading to lower operating costs compared to competitors.
- The process maximizes water conservation by recycling up to 98% of water and re-injecting remaining brine into the reservoir, minimizing environmental impact.
- Modular design of the MDLE Plant allows for customization to site-specific requirements, reduced capital expenditure (CapEx), and scalability by adding modules with minimal disruption.
- Successfully raised approximately $24.4 million in private placements during fiscal year 2025, and secured an additional $5.0 million from the 2025 Encompass Offering, expected to close soon.
- The company has a strong intellectual property portfolio with four issued patents and twenty-four pending patent applications, along with registered trademarks.
- A significant legal proceeding with former employees and directors was settled, resolving a long-standing dispute.
Negatives
- The company is a pre-revenue, development-stage company with a very limited history of operations and has historically incurred substantial losses.
- The commercial-scale demonstration project with US Magnesium was terminated earlier than anticipated in September 2024 due to low lithium demand and market prices, preventing the achievement of defined production targets.
- The company realized a net loss of $3.5 million for the fiscal year ended March 31, 2025, and $8.5 million for March 31, 2024, with an accumulated deficit of $39.6 million as of March 31, 2025.
- The business plan is untested, and the royalty structure for lithium extraction remains largely undefined, creating uncertainty regarding future profitability.
- The company expects to be highly dependent on a limited number of customers, increasing risks related to customer financial condition and contractual performance.
- The market for lithium-based products, particularly EVs, has seen a slowdown in sales growth, leading to market perception of oversupply and dramatic price declines for lithium carbonate and hydroxide.
- The company has identified a material weakness in its internal controls over financial reporting related to the capitalization of capital assets and determination of their useful lives, which led to a restatement of prior financial statements.
- The company's common shares are thinly traded on the TSX Venture Exchange and OTCQB, and are considered a 'penny stock,' subject to additional sale and trading regulations and risks of fraud and abuse.
Risks
- Ability to raise sufficient capital to fund operations and customize MDLE Plants for customers.
- Continued operating losses and uncertainty regarding achieving or maintaining profitability.
- Difficulty in identifying and successfully negotiating commercially reasonable lease and service agreements with potential customers.
- Untested business plan and no generally accepted measure of market size for lithium-based products, making financial forecasting difficult.
- Intense competition from other DLE technology developers and traditional mining companies, many with greater financial resources.
- Volatility in demand and market prices for lithium, which could negatively impact revenue and profitability.
- Failure to enter into and deliver lithium carbonate product under offtake agreements, or incurring production costs exceeding agreed prices.
- Risk to the growth of lithium markets and the supply of lithium sources, including slower EV adoption rates or development of alternative battery technologies.
- Reliance on management and key employees, and the ability to attract, train, and retain qualified personnel in a competitive environment.
- Exposure to hazards common to chemical and natural resource extraction businesses, including explosions, fires, and mechanical failures, which could interrupt production and damage reputation.
- Uncertain geopolitical tensions, particularly between the United States and China, which may adversely affect demand for lithium-based products or impede foreign market contracts.
- Potential for claims and other legal actions, which can be costly and divert management attention.
- Dependence on a small group of customers for most revenue, increasing vulnerability to customer financial condition or discontinuation of services.
- Dependence on third-party suppliers for components and raw materials, risking supply chain disruptions and increased costs.
- Global financial conditions posing risks to liquidity, capital raising, and commodity prices.
- Inability to obtain or maintain sufficient general liability insurance to cover potential risks and hazards.
- Increased cybersecurity requirements, vulnerabilities, and threats posing risks to systems, networks, and data.
- Potential conflicts of interest due to directors and officers serving on boards of other companies.
- Strain on resources and diversion of management attention due to requirements of being a reporting public company in the United States.
- Changes in U.S. tax laws and tax examinations could materially affect tax expense and profitability.
- Risks relating to natural disasters, public health crises, political crises, and other catastrophic events outside of control.
- Compliance with anti-corruption and bribery laws, with potential for significant penalties for violations.
- Potential classification as a Passive Foreign Investment Company (PFIC), which could result in adverse U.S. federal income tax consequences to U.S. investors.
- Subject to stringent domestic and international regulatory approvals for MDLE Plant development, testing, manufacture, and installation, with no assurance of timely approval.
- Environmental risks and stringent regulations related to lithium-based products, potentially leading to additional disclosure requirements and substantial expenditures.
- Canadas new modern slavery reporting legislation (FAFLCL) may adversely affect supply chains and business, requiring capital expenditures for compliance.
- Patent terms may be inadequate to protect competitive position, and intellectual property rights may not address all potential threats.
- Risk of claims that employees, consultants, or independent contractors have wrongfully used or disclosed confidential information of former employers or third parties.
- Thinly traded common shares on TSX Venture Exchange and OTCQB, leading to price volatility and potential difficulty for investors to liquidate investments.
- Potential for immediate dilution and share price decline if additional common shares are sold in future financings or issued related to warrants, options, and restricted share units.
- Volatility in share price caused by message board and social media influences, potentially leading to stock price collapse.
- Common shares considered a 'penny stock,' subject to additional sale and trading regulations and risks associated with fraud and abuse in the penny stock market.
- Techniques employed by short sellers may drive down the market price of the common shares.
Future Outlook
The company plans to deploy its current MDLE Plant in a new commercial setting, continue research and development for a second generation of MDLE technology to increase capacity and processing options, and expand into new geographic areas, particularly North America, Argentina, and Chile. It also intends to license its technology to lithium brine resource developers and evaluate joint venture opportunities for full development of lithium brine resources.
Management Comments
- Our proprietary extraction process is sustainable, low cost and capable of producing high-quality commercial grade lithium products.
- We believe that our strategy of employing advanced brine extraction technologies and methodologies for selective mineral extraction is less capital intensive and a more environmentally responsible approach compared to traditional lithium extraction processes.
- We are currently in the preliminary stages of researching and developing the media and design for the Second Generation of MDLE Technology which we anticipate could provide customers with additional options for processing brine solutions and increasing lithium chloride production.
- We believe there is increasing support by U.S. and international governments for the sustainable production of lithium compounds.
- We believe there will be opportunities to license our technology to lithium brine resource developers to allow them to deploy our proprietary columns, media, and processes in their plant and developments.
- We will evaluate opportunities to enter into joint venture agreements or strategic partnerships with one or more parties, including landowners, producers and financial backers, to participate in the full development of lithium brine resources.
- We believe that the modular design of our proprietary and patented MDLE Plant provides an economic advantage compared to existing alternative technologies based on our ability to customize the plant to reflect site limitations and requirements.
- As a result of our highly selective absorption process and the elimination of chemicals from the extraction process, we believe our MDLE Plant is more efficient for customers and has lower operating costs as compared to our DLE competitors.
- While the cash from the private placements is anticipated to support the Company’s operations, the Company continues to incur operating losses and negative cash flows and therefore will need to continue to rely on private placements to support the Company’s operations until we have entered into an agreement for the placement of our MDLE Plant.
Industry Context
The lithium-ion battery market, driven by vehicle electrification, is the primary growth driver for lithium demand. However, recent market forecasts indicate a slowdown in EV sales growth, leading to a perception of oversupply and a dramatic decline in lithium prices. This emphasizes the importance of low-cost lithium extraction technology. The industry is shifting towards Direct Lithium Extraction (DLE) technologies due to the high environmental costs and water consumption associated with traditional hard rock mining and solar evaporation ponds. The company positions its MDLE technology as a sustainable, low-cost alternative in this evolving market, aiming to address environmental concerns and meet the demand for high-purity lithium compounds.
Comparison to Industry Standards
- The company's MDLE Plant produced approximately 25 tons of battery-grade lithium carbonate with over 99% purity, demonstrating commercial-scale capability.
- In a September 2022 pilot test, the MDLE Plant achieved an average of 81% lithium extraction and 69% lithium recovery to product, with 94% water recovery. A June 2023 third-party test confirmed 95% overall lithium recovery.
- Traditional solar evaporation for lithium extraction consumes over 180 metric tons of water per 1 metric ton of lithium produced, whereas the company's MDLE process is designed to recycle up to 98% of process water and re-inject brine, significantly reducing water usage and environmental impact.
- Unlike some competing DLE technologies that use acids and bases (e.g., selective membranes and ion exchanges), the company's proprietary absorption process eliminates the need for hydrochloric acid and sodium hydroxide, reducing chemical waste and associated disposal costs.
- The modular design of the MDLE Plant allows for deployment in 18-24 months, significantly faster than traditional lithium extraction solutions which can take five to six years to construct.
- The company claims lower capital and operating expenses for its MDLE Plant compared to DLE competitors, enabling faster profitability for customers.
Management Changes
| Role | Previous Person | New Person | Effective Date | Reason |
|---|---|---|---|---|
| Chief Executive Officer, Director | Iris Jancik | Joseph A. Mills | 2025-04-07 | Appointment to lead the company, bringing extensive experience in oil & gas and public company leadership. |
| Chief Financial Officer | Douglas Smith | Michael Rutledge | 2025-06-02 | Appointment to lead financial operations, bringing experience from public companies and IPOs. |
| Chief Executive Officer | Garry Flowers | 2024-08-20 | Resignation from the role. | |
| Co-Chief Executive Officer | Libor Michel | 2024-04-10 | Resignation from the role. | |
| General Counsel, Corporate Secretary | Norma Garcia | 2024-11-18 | Appointment to lead legal and corporate secretarial functions. | |
| Chairman of the Board | Dr. John Burba | 2024-11-01 | Appointment to lead the Board, in addition to his CTO role. | |
| Director | Tony Colletti | 2024-10-31 | Service as director ended. | |
| Director | Daniel Layton | 2024-09-25 | Service as director ended. | |
| Director | William Webster | 2024-10-31 | Service as director ended. | |
| Director | James Schultz | 2024-10-01 | Appointment to the Board. | |
| Director | Keith Solar | 2024-11-01 | Appointment to the Board. | |
| Director | John Souther | 2024-11-01 | Appointment to the Board. |
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Board Composition | The Board of Directors currently consists of six directors. The company evaluates director independence in accordance with National Policy 58-201 and National Instrument 58-101 (Canadian standards). | Ensures compliance with Canadian corporate governance guidelines for board independence. | |
| Director Independence Determination | James Schultz, Keith Solar, and John Souther are considered independent directors. Dr. John Burba, Mr. Jacob Warnock, and Mr. Joseph Mills are not considered independent. | Maintains a mix of independent and non-independent directors, with independent directors forming a majority on key committees. | |
| Audit Committee Composition | The Audit Committee consists of John Souther, James Schultz (Chairman), and Keith Solar. All members meet heightened independence requirements under NI 52-110, and James Schultz is an audit committee financial expert. | Strengthens financial oversight and ensures compliance with regulatory requirements for audit committees. | |
| Corporate Governance, Nominating & Compensation Committee (CGNC) Composition | The CGNC Committee consists of Keith Solar (Chairman), John Souther, and Jacob Warnock. | Provides structured oversight for corporate governance, director nominations, and executive compensation. | |
| Code of Conduct | A written Code of Conduct, amended in March 2025, applies to all directors, officers, and employees, prohibiting conflicts of interest and outlining ethical standards. | 2025-03-01 | Enhances ethical conduct and compliance across the organization, with clear guidelines for conflicts of interest and related party transactions. |
| Director Indemnification | The company's Articles and BCBCA provisions allow for indemnification of directors and officers to the fullest extent permitted by law. Indemnity agreements have been entered into with certain directors and executive officers. | Aids in attracting and retaining qualified individuals by mitigating personal liability risks, but may use corporate resources. | |
| Investor Rights Agreement Amendment | An amendment to the investor rights agreement with EV Metals grants EV Metals the right to approve one additional independent director if the board is comprised of more than five individuals, as long as EV Metals maintains at least 5% beneficial ownership. | 2025-03-31 | Increases influence of a significant shareholder (EV Metals) on board composition, potentially impacting strategic decisions. |
| Warrant Term Extension and Amendments | Warrant expiration dates for certain private placements (April 2023, February 2024, May 2024, June 2024) were extended to the earlier of five years from original issuance or three years from the 2025 Encompass Offering closing, subject to TSXV approval. Exercise limitations were also amended. | 2025-07-20 | Extends the period for warrant holders to exercise, potentially providing more capital to the company upon exercise, but also extends potential dilution. The exercise limitation amendment impacts beneficial ownership thresholds. |
Legal Proceedings
- On April 23, 2021, former employees and directors, Ms. Christina Borgese and Mr. Marc Privitera, filed claims against the company in the United States District Court for the District of Colorado, alleging wrongful dismissal and breach of a share exchange agreement, including non-payment of wages and benefits, appropriation of property, and interference in outside employment.
- The company filed a counterclaim alleging the counterclaim defendants diverted company work and interfered with contractual relations.
- On September 30, 2024, the Court largely granted the company's motion for summary judgment, dismissing some of the plaintiffs' claims.
- On July 14, 2025, the claims were dismissed following a settlement agreement reached on April 28, 2025, whereby the company paid the claimants approximately $78,000.
Related Party Transactions
- Royalty Agreement with North American Lithium, Inc. (NAL) (controlled by Dr. John Burba, CTO) from March 4, 2018, entitling NAL to a 5% royalty on product income. The company does not anticipate selling products in the foreseeable future, but rather leasing MDLE Plants, which would generate lease and service revenue, not product income.
- Exclusive licensing agreement from November 7, 2018, with Ensorcia Metals and Sorcia Minerals (controlled by Daniel Layton, a former director and >5% shareholder) for technology use in Chile and Argentina, entitling the company to a 6% royalty on net sales and a 10% equity interest in each project, provided an MDLE Plant is operational by December 31, 2028.
- Non-exclusive, world-wide licensing agreement from March 30, 2023, with Entec LLC (controlled by Daniel Layton) for access to IP Rights, entitling the company to a 6% royalty on net sales and a 10% interest in the first resource project, with similar terms for additional projects.
- Private placement transactions in December 2023 and February 2024 involved current and former executive officers (Garry Flowers, Dr. John Burba, Douglas Smith) and a director (Jacob Warnock, who controls EV Metals VI), subscribing for units of common shares and warrants.
- EV Metals VI (controlled by Jacob Warnock) acquired units in May 2024 and June 2024 private placements, and the company paid structuring and financing fees to EV Metals VI or Jacob Warnock, including through issuance of common shares.
- The company had an outstanding payable of approximately $710,000 to EVL Holdings, LLC (a >10% shareholder) as of March 31, 2024, related to MDLE Plant construction, which was paid subsequent to that date.
- The 2025 Letter Agreement with EV Metals 7 LLC (controlled by Jacob Warnock) allows EV Metals to purchase up to $15.0 million in units, with initial issuances totaling $8.229 million in March and April 2025. Structuring fees of $411,450 were paid to Mr. Warnock.
- An amendment to the investor rights agreement (March 31, 2025) grants EV Metals the right to approve one additional independent director if the board has more than five individuals, as long as EV Metals maintains at least 5% beneficial ownership.
- Binding subscription agreements with Encompass (a >5% beneficial owner) on July 20, 2025, for $5.0 million in units, with an option for an additional $2.0 million.
- Amended and restated registration rights agreements (July 20, 2025) with EV Metals and Encompass, extending warrant expiration dates and including cross-indemnification provisions. The company will pay certain registration expenses.
Stakeholder Impact
- **Shareholders**: Face significant dilution from ongoing and future equity financings (e.g., 93.48 million common shares and 39.22 million warrants registered for resale, plus 25.77 million units from the 2025 Encompass Offering). The stock is thinly traded and considered a penny stock, increasing volatility and liquidity risks. Existing shareholders may experience immediate dilution and potential decline in share price.
- **Employees/Management**: The company relies heavily on its management and key employees, and its ability to attract and retain talent is crucial. New executive appointments (CEO, CFO, General Counsel) indicate a refreshed leadership team. Compensation includes significant equity awards (RSUs, stock options) tied to performance and company milestones, aligning interests but also creating potential for forfeiture if targets are not met or employment terminates.
- **Customers**: Potential customers benefit from the company's DLE technology, which offers lower CapEx, OpEx, and a smaller environmental footprint compared to traditional methods. However, the termination of the US Magnesium project highlights the risk of customer adoption and the impact of market prices on their profitability, which could affect future contracts.
- **Suppliers**: The company's dependence on third-party suppliers for components and raw materials introduces supply chain risks that could affect its ability to deliver MDLE Plants.
- **Creditors**: The company's reliance on equity financing and accumulated deficit indicates a higher risk profile for creditors, as conventional bank financing has historically been unavailable.
- **Regulatory Bodies**: The company is subject to extensive and evolving environmental, securities, and anti-corruption regulations in both Canada and the U.S., requiring significant compliance efforts and potential costs. The identified material weakness in internal controls over financial reporting could lead to regulatory scrutiny.
Next Steps
- Deploy the current MDLE Plant with new industrial customers.
- Continue research and development for the Second Generation of MDLE Technology, including laboratory studies for optimal process using larger diameter columns.
- Expand operations into new geographic areas, including North America, Argentina, and Chile.
- License its technology to lithium brine resource developers.
- Evaluate opportunities to enter into joint venture agreements or strategic partnerships for full development of lithium brine resources.
- Host large-scale demonstrations of the MDLE Plant using existing case study data to attract additional project opportunities and fabrication orders.
- Complete design and engineering work on the second-generation version of the MDLE Plant modules.
- Remediate the identified material weakness in internal controls over financial reporting by establishing and implementing a formal written policy for capital asset accounting and additional review controls.
- Close the 2025 Encompass Offering around August 8, 2025, subject to regulatory approvals and customary closing conditions.
- File a registration statement for the common shares and warrants from the 2025 Encompass Offering within 90 days of closing, and have it declared effective within 60-180 days.
- Potentially facilitate up to two underwritten offerings requested by EV Metals prior to the third anniversary of the S-1 effective date, provided the aggregate price is $25 million or less.
Key Dates
| Date | Description |
|---|---|
| 2010-07-29 | Company incorporated under the Business Corporations Act (British Columbia). |
| 2018-04-13 | Acquisition of North American Lithium, Inc. (NAL) data and Selective Adsorption Lithium, Inc. (SAL) shares and intellectual property, marking the company's focus on Dr. Burba's lithium extraction technologies. |
| 2018-06-26 | Dr. John Burba's executive employment agreement commenced as CEO. |
| 2018-09-01 | Company changed its name to International Battery Metals, Inc. |
| 2018-11-07 | Entered into exclusive licensing agreements with Ensorcia Metals and Sorcia Minerals for technology use in Chile and Argentina. |
| 2021-02-19 | Entered into a private placement transaction with Sorcia Minerals and EVL Holdings for units of common shares and warrants. |
| 2021-04-23 | Former employees Christina Borgese and Marc Privitera filed claims against the company in U.S. District Court for the District of Colorado. |
| 2022-05-16 | Entered into investment agreements with EVL Holdings and Sorcia Minerals for assumption of MDLE Plant fabrication costs. |
| 2022-07-01 | Garry Flowers' executive employment agreement commenced as President. |
| 2022-08-15 | Sold 400,000 Common Shares at CAD$0.19 and 100,000 Common Shares at CAD$0.38 upon exercise of Stock Options. |
| 2022-09-01 | Pilot test of MDLE Plant achieved 81% lithium extraction and 69% lithium recovery to product. |
| 2022-10-07 | Sold 2,550,000 Common Shares at CAD$0.38 upon exercise of Stock Options. |
| 2022-10-20 | Issued 300,000 Common Shares at CAD$0.62 upon exercise of Stock Options. |
| 2022-12-02 | Garry Flowers promoted to Chief Executive Officer. |
| 2023-01-30 | Issued 3,331,162 Common Shares to Ensorcia Metals and another accredited investor upon exercise of pre-emptive rights. |
| 2023-02-07 | Issued 5,024,331 Common Shares to Dr. Burba upon completion of milestone achievements. |
| 2023-03-10 | Held special meeting of shareholders to re-approve 2021 Private Placement and re-affirm pre-emptive rights. |
| 2023-03-21 | Completed 2021 Private Placement, issuing units to EVL Holdings LLC and Sorcia Minerals LLC. |
| 2023-03-22 | Issued 5,024,331 Common Shares to Christina Borgese and 5,024,330 Common Shares to Marc Privitera upon completion of milestone achievements. |
| 2023-03-30 | Entered into a non-exclusive, world-wide licensing agreement with Entec LLC (Entec), an affiliate of Ensorcia Group. |
| 2023-04-20 | Sold 422,498 Common Shares upon exercise of Warrants by Sorcia Minerals. |
| 2023-04-21 | Completed a non-brokered private placement (April 2023 Placement) with Encompass, issuing 6,396,999 Units. |
| 2023-06-07 | Amended the exercise price of 1,800,000 stock options previously granted to officers, directors, and employees. |
| 2023-06-30 | Granted 12,500 RSUs to an employee and concurrently issued the shares to settle them. |
| 2023-07-04 | Sold 12,500 Common Shares upon vesting of RSUs. |
| 2023-07-07 | Issued replacement options following a thirty-day grace period at the amended exercise price of CAD$1.41 per share. |
| 2023-07-26 | Dr. John Burba assumed the role of Chief Technology Officer. |
| 2023-08-28 | Sold 800,000 Common Shares at CAD$0.19 upon exercise of Stock Options. |
| 2023-09-21 | Sold 400,000 Common Shares at CAD$1.195 to a service provider. |
| 2023-09-29 | 220,902 RSUs converted to 220,902 Stock Options. |
| 2023-12-08 | Completed a private placement financing of 1,629,838 units for gross proceeds of approximately $840,000. |
| 2023-12-11 | Douglas Smith's executive employment agreement commenced as Chief Financial Officer; Libor Michel's executive employment agreement commenced as Co-Chief Executive Officer. |
| 2023-12-15 | Amended and restated Restricted Share Unit Plan adopted. |
| 2023-12-29 | Completed a private placement financing of 2,694,804 units for gross proceeds of approximately $1.4 million. |
| 2024-02-11 | Entered into a binding term sheet with EV Metals VI for up to $20 million in units. |
| 2024-02-29 | Completed first closing of private placement with EV Metals VI, issuing 2,702,400 units for $2 million. |
| 2024-03-27 | Issued 76,005 Common Shares to directors and Corporate Secretary in lieu of cash payment. |
| 2024-04-10 | Libor Michel resigned as Co-Chief Executive Officer. |
| 2024-05-01 | Entered into a lease agreement with US Magnesium LLC for the MDLE Plant. |
| 2024-05-06 | Completed a private placement with EV Metals VI and Encompass, issuing 18,642,134 units for approximately $10.4 million. |
| 2024-05-09 | Issued 80,385 Common Shares to Encompass as payment for expenses. |
| 2024-05-31 | Issued 14,624 Common Shares upon vesting of RSUs. |
| 2024-06-01 | Completed commission of the MDLE Plant at US Magnesium's facility, and US Magnesium assumed operational control. |
| 2024-06-19 | Completed another private placement with EV Metals VI and Encompass, issuing 11,478,246 units for approximately $6.4 million. |
| 2024-08-11 | Iris Jancik's executive employment agreement commenced as Chief Executive Officer. |
| 2024-08-20 | Garry Flowers resigned as Chief Executive Officer; granted 4,227,630 performance-based RSUs (300,000 vested upon issuance) and 2,113,814 stock options to a Rule 701 Eligible Person. |
| 2024-09-25 | US Magnesium suspended operations of the MDLE Plant at their site due to low demand and market price of lithium, terminating the lease agreement. |
| 2024-09-30 | Court granted company's motion for summary judgment in Borgese/Privitera lawsuit, dismissing some claims. |
| 2024-10-13 | Norma Garcia's offer letter commenced as General Counsel. |
| 2024-10-31 | Tony Colletti and William Webster's service as directors ended. |
| 2024-11-01 | CBIZ CPAs P.C. became the company's auditor (acquisition of Marcum LLP's attest business). |
| 2024-11-11 | Plaintiffs and company filed joint notice of remaining claims in Borgese/Privitera lawsuit. |
| 2024-11-16 | Entered into a new sub-lease agreement for office space in Plano, Texas. |
| 2024-11-18 | Norma Garcia appointed as General Counsel, Corporate Secretary. |
| 2024-11-24 | Award of RSUs issued to each director as compensation. |
| 2024-11-26 | Granted 2,705,630 RSUs to the Board of Directors. |
| 2024-11-30 | Houston office lease ended. |
| 2024-12-01 | Dr. Burba appointed as Chairman of the Board. |
| 2025-02-28 | Entered into a letter agreement with EV Metals 7 LLC for potential purchase of up to $15.0 million in units. |
| 2025-03-02 | EV Metals 7 LLC and EV Metals VI LLC entered into binding subscription agreements for a portion of the 2025 EV Metals Offering. |
| 2025-03-04 | Entered into a Severance and General Release Agreement with Douglas Smith, terminating his employment. |
| 2025-03-06 | Douglas Smith's service as Chief Financial Officer ended. |
| 2025-03-25 | Code of Conduct amended. |
| 2025-03-31 | First issuance under the 2025 Letter Agreement occurred for gross proceeds of $7.55 million; entered into an amendment to the investor rights agreement with EV Metals. |
| 2025-04-07 | Joseph Mills' executive employment agreement commenced as Chief Executive Officer. |
| 2025-04-11 | Second issuance under the 2025 Letter Agreement occurred for gross proceeds of $679,000; entered into a Severance and General Release Agreement with Iris Jancik, terminating her employment. |
| 2025-04-17 | Filed shelf Registration Statement on Form S-1 (No. 333-286616) with the SEC. |
| 2025-04-18 | Joseph Mills' Restricted Share Unit Agreement effective. |
| 2025-04-28 | Parties engaged in a settlement conference for the Borgese/Privitera lawsuit. |
| 2025-06-02 | Michael Rutledge's executive employment agreement commenced as Chief Financial Officer; Michael Rutledge's Restricted Share Unit Agreement effective. |
| 2025-07-14 | Claims in Borgese/Privitera lawsuit dismissed due to settlement agreement. |
| 2025-07-20 | Entered into binding subscription agreements with Encompass for the purchase of up to 25,765,259 units for $5.0 million; entered into amended and restated registration rights agreements with EV Metals and Encompass; agreed to extend warrant expiration dates. |
| 2025-07-22 | Common Shares outstanding: 271,338,418. |
| 2025-07-29 | Last reported sale price of Common Shares on TSXV was CAD$0.32 (US$0.232); last reported sales price on OTCQB was US$0.233. |
| 2025-07-30 | Date of this S-1/A filing. |
| 2025-08-08 | Expected closing date of the 2025 Encompass Offering. |
| 2025-11-15 | Termination date for the Encompass Subscription Agreement if the offering is not consummated. |
| 2025-11-26 | RSUs granted to Dr. Burba will vest. |
| 2025-12-31 | Deadline for Encompass to exercise option to purchase up to $2.0 million additional units. |
| 2026-03-01 | Original expiration date of February 2024 Warrants. |
| 2026-03-04 | Douglas Smith's stock options expire. |
| 2026-05-03 | Original expiration date of May 2024 Warrants. |
| 2026-06-02 | Michael Rutledge's 450,000 RSUs will vest. |
| 2026-06-19 | Original expiration date of June 2024 Warrants. |
| 2026-07-20 | Latest date for the Initial Form S-1 to be declared effective under the Securities Act. |
| 2027-08-01 | Principal corporate office lease expires. |
| 2028-04-21 | New expiration date for 2023 Warrants. |
| 2028-05-03 | New expiration date for May 2024 Warrants (if 5 years from issuance is earlier than 3 years from 2025 Encompass Offering close). |
| 2028-05-03 | Dr. John Burba's 300,000 stock options expire. |
| 2028-06-19 | New expiration date for June 2024 Warrants (if 5 years from issuance is earlier than 3 years from 2025 Encompass Offering close). |
| 2028-12-31 | Latest date for MDLE Plant to be installed and operational for Ensorcia Licensing Agreement to maintain exclusivity. |
| 2030-02-12 | Norma Garcia's 400,000 stock options expire. |
| 2031-01-01 | Earliest expiration date for Canadian non-capital tax loss carryforwards. |
| 2034-08-20 | Iris Jancik's 1,261,512 stock options were scheduled to vest. |
| 2045-01-01 | Latest expiration date for Canadian non-capital tax loss carryforwards. |
Recommendation
holdThe company presents a high-risk, high-reward profile. While its proprietary DLE technology offers significant competitive advantages in terms of environmental sustainability, cost efficiency, and modularity, the company is still in its early commercialization stage, is pre-revenue, and has a substantial accumulated deficit. The recent termination of a key demonstration project due to market conditions underscores the inherent volatility and challenges in the lithium market. The ongoing need for capital raises, despite recent successes, indicates continued financial dependence. The identified material weakness in internal controls also adds a layer of operational risk. For a seasoned investor, the innovative technology and potential for future growth in the green energy sector are attractive, but the significant execution risks, market uncertainties, and pre-revenue status warrant a 'hold' rather than a 'buy' or 'sell' recommendation. It's a speculative investment that requires close monitoring of commercialization progress, customer acquisition, and market conditions.
Keywords
Lithium Extraction, Direct Lithium Extraction, DLE, MDLE Plant, Battery Metals, Lithium Carbonate, Brine Extraction, Green Energy, EV Market, Environmental Sustainability, SEC Filing, S-1/A, Private Placement, Warrants, Corporate Governance, Risk Factors, Intellectual Property, TSX Venture Exchange, OTCQB
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.